WFH Advocates for Hemophilia Care Access at WHO EMRO Meeting in Cairo
World Federation of Hemophilia / Fédération mondiale de l’hémophilie posted on LinkedIn:
”During the 72nd Session of the WHO Regional Committee for the Eastern Mediterranean in Cairo, Egypt, WFH Regional Manager Rana Saifi delivered a statement advocating for the inclusion of hemophilia and other Bleeding Disorders in the WHO EMRO flagship initiative to expand access to quality medical products in the region.
This aligns with the recent WHO 2025 Essential Medicines List updates, a critical step forward that requires concrete regional and national action to ensure access to lifesaving treatments.
Saifi also voiced WFH’s strong support for a WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Inherited Bleeding Disorders, proposed for discussion at the 158th session of the WHO Executive Board and backed by several Member States including Armenia, Morocco, with support from Egypt, Nepal and Sri Lanka.
Read the full statement here.”
Stay updated with Hemostasis Today.
-
Apr 23, 2026, 18:19Chokri Ben Lamine: Choosing the Right LMWH in Cancer Patients
-
Apr 23, 2026, 17:57Shalini R: Not All Blood Thinners Are the Same
-
Apr 23, 2026, 17:33Abdulaziz (Omar) Badran: Navigating the Clinical Complexity of Combined Red Cell Disorders
-
Apr 23, 2026, 17:19Kate Thomas: One Hour, One Donation, One Life Saved
-
Apr 23, 2026, 17:19Ameneh Eshghinejad: The First 72 Hours After SAH Are Critical for Balancing the Risks of Rebleeding and Thromboembolism
-
Apr 23, 2026, 17:18Katarina Ziakova: The WFH Shared Decision – Making Tool Is Driving Critical Conversations in Haemophilia Care
-
Apr 23, 2026, 17:14Paulus Kirchhof: Can We Improve Prevention of Cardiovascular Diseases?
-
Apr 23, 2026, 17:08Wolfgang Miesbach: 5‑Year Gene Therapy Data from WFH Congress 2026
-
Apr 23, 2026, 17:05Veronica Sanchez: The 2026 Guideline on the Management of Dyslipidemia